Discrepancies in Liver Disease Labeling in the Package Inserts of Commonly Prescribed Medications

被引：13

作者：

Bjornsson, Einar S. ^{[1
]}

Jacobsen, Elin I. ^{[1
]}

Einarsdottir, Rannveig ^{[1
]}

Chalasani, Naga ^{[2
]}

机构：

[1] Natl Univ Iceland, Reykjavik, Iceland

[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

来源：

GASTROENTEROLOGY | 2015年 / 148卷 / 02期

关键词：

NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CIRRHOSIS;

D O I：

10.1053/j.gastro.2014.12.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：269 / 273

页数：5

相关论文

共 8 条

[1]

BRANCH R A, 1976, Clinical Pharmacokinetics, V1, P264

[2]

Anti-inflammatory drugs and variceal bleeding:: a case-control study [J].

De Lédinghen, V ;

Heresbach, D ;

Fourdan, O ;

Bernard, P ;

Liebaert-Bories, MP ;

Nousbaum, JB ;

Gourlaouen, A ;

Becker, MC ;

Ribard, D ;

Ingrand, P ;

Silvain, C ;

Beauchant, M .

GUT, 1999, 44 (02) :270-273

[3]

Non-steroidal anti-inflammatory drugs and variceal bleeding: A case-control study [J].

deLedinghen, V ;

Mannant, PR ;

Foucher, J ;

Perault, MC ;

Barrioz, T ;

Ingrand, P ;

Vandel, B ;

Silvain, C ;

Beauchant, M .

JOURNAL OF HEPATOLOGY, 1996, 24 (05) :570-573

[4]

Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations [J].

Franz, Carmen C. ;

Hildbrand, Carole ;

Born, Christa ;

Egger, Sabin ;

Bravo, Alexandra E. Raetz ;

Kraehenbuehl, Stephan .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (08) :1565-1573

[5]

Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis [J].

Franz, Carmen C. ;

Egger, Sabin ;

Born, Christa ;

Bravo, Alexandra E. Raetz ;

Kraehenbuehl, Stephan .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (02) :179-188

[6]

Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients [J].

Lee, Yen-Chieh ;

Chang, Chia-Hsuin ;

Lin, Jou-Wei ;

Chen, Hsi-Chieh ;

Lin, Min-Shung ;

Lai, Mei-Shu .

LIVER INTERNATIONAL, 2012, 32 (05) :859-866

[7]

Drug use for non-hepatic associated conditions in patients with liver cirrhosis [J].

Lucena, MI ;

Andrade, RJ ;

Tognoni, G ;

Hidalgo, R ;

de la Cuesta, FS .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (01) :71-76

[8]

INFLUENCE OF CIRRHOSIS ON STEADY-STATE BLOOD-CONCENTRATIONS OF UNBOUND PROPRANOLOL AFTER ORAL-ADMINISTRATION [J].

WOOD, AJJ ;

KORNHAUSER, DM ;

WILKINSON, GR ;

SHAND, DG ;

BRANCH, RA .

CLINICAL PHARMACOKINETICS, 1978, 3 (06) :478-487